Abstract
Many immune‑related Adverse Events (irAEs) resolve after discontinuation of Immune Checkpoint Inhibitors (ICIs) and treatment with immunosuppression, most commonly corticosteroids. However, some irAEs can recur or persist after discontinuation of ICIs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have